YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Sept. 17, 2014 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ), an innovative medical device company that designs, develops and markets wearable robotic exoskeletons for individuals with spinal cord injury, today announced the closing of its initial public offering of 3,450,000 ordinary shares at $12.00 per share, which includes 450,000 ordinary shares purchased pursuant to the full exercise of the underwriters' option to purchase additional shares. All shares were issued and sold by ReWalk.
Barclays Capital Inc. and Jefferies LLC are the joint book-running managers for the offering. Canaccord Genuity Inc. is the co-manager for the offering.
A copy of the final prospectus related to the offering may be obtained when available from: Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Ave, Edgewood, NY 11717, 888-603-5847, email: Barclaysprospectus@broadridge.com or Jefferies LLC, 520 Madison Ave, 2nd Floor, New York, NY 10022, 877-547-6340, email: Prospectus_Department@Jefferies.com.
A registration statement relating to these securities has been filed and declared effective by the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the offered securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. (formerly Argo Medical Technologies Ltd.) designs, develops and markets wearable robotic exoskeletons for individuals with spinal cord injury. ReWalk's mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. Founded in 2001, ReWalk has headquarters in the US, Israel and Germany.
Lisa Wilson In-Site Communications, Inc. Investor Relations T: (212) 452-2793 E:
